货号:A194638
同义名:
盐酸瓦地那非三水合物
/ Vardenafil(hydrochloride hydrate); BAY38-9456
Vardenafil HCl Trihydrate是一种PDE抑制剂,IC50分别为0.7 nM(对PDE5)和180 nM(对PDE1)。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | PDE ↓ ↑ | PDE1 ↓ ↑ | PDE10A ↓ ↑ | PDE2 ↓ ↑ | PDE3 ↓ ↑ | PDE4 ↓ ↑ | PDE5 ↓ ↑ | PDE6 ↓ ↑ | 其他靶点 | 纯度 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Doxofylline | ✔ | 99+% | |||||||||||||||||
| Deltarasin |
+++
PDEδ , Kd: 38 nM |
95% | |||||||||||||||||
| 7-(2,3-Dihydroxypropyl)theophylline | ✔ | 98% | |||||||||||||||||
| Aminophylline |
+
PDE, IC50: 0.12 mM |
98+% | |||||||||||||||||
| Anagrelide HCl | ✔ | 99%+ | |||||||||||||||||
| Irsogladine | ✔ | AChR,mAChR | 99% | ||||||||||||||||
| PF-8380 |
+++
Autotaxin, IC50: 2.8 nM |
99%+ | |||||||||||||||||
| Dipyridamole | ✔ | 98% | |||||||||||||||||
| Balipodect |
++++
PDE10A, IC50: 0.3 nM |
99%+ | |||||||||||||||||
| Luteolin |
+
PDE1, Ki: 15.0 μM |
++
PDE2, Ki: 6.4 μM |
+
PDE3, Ki: 13.9 μM |
+
PDE4, Ki: 11.1 μM |
+
PDE5, Ki: 9.5 μM |
98% | |||||||||||||
| Milrinone |
++
PDE2, IC50: 5.2 μM |
++
PDE3, IC50: 2.1 μM |
ATPase | 99% | |||||||||||||||
| Pimobendan |
++
PDE3, IC50: 0.32 μM |
98% | |||||||||||||||||
| Cilostazol |
++
PDE3, IC50: 0.2 μM |
98% | |||||||||||||||||
| Fenspiride HCl |
+
PDE3, pIC50: 3.44 |
+
PDE4, pIC50: 4.16 |
99% (HPLC) | ||||||||||||||||
| (S)-(+)-Rolipram |
++
PDE4, IC50: 0.75 μM |
99% (HPLC) | |||||||||||||||||
| Apremilast |
+++
PDE4, IC50: 74 nM |
98% | |||||||||||||||||
| GSK256066 |
++++
PDE4B, IC50: 3.2 pM |
98+% | |||||||||||||||||
| Roflumilast |
++++
PDE4A1, IC50: 0.7 nM PDE4A4, IC50: 4.3 nM |
99% | |||||||||||||||||
| Rolipram |
+++
PDE4B, IC50: 130 nM |
99%+ | |||||||||||||||||
| Cilomilast |
+++
LPDE4, IC50: 100 nM HPDE4, IC50: 120 nM |
99% | |||||||||||||||||
| Avanafil |
++++
PDE5, IC50: 1 nM |
98% | |||||||||||||||||
| Vardenafil HCl Trihydrate |
++++
PDE5, IC50: 0.7 nM |
98% | |||||||||||||||||
| Tadalafil |
++++
PDE5, IC50: 1.8 nM |
98% | |||||||||||||||||
| Icariin |
++
PDE5, IC50: 0.432 μM |
98% | |||||||||||||||||
| Sildenafil | ✔ |
+++
PDE6, IC50: 33 nM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Phosphodiesterase-5 (PDE5) is 1 of 11 mammalian PDE families known to date. PDE5 is a cGMP-specific PDE and is abundant in most smooth muscle tissues as well as in platelets, gastrointestinal epithelial cells, and Purkinje cells of the cerebellum[3]. Vardenafil specifically inhibits the hydrolysis of cGMP by PDE5 with an IC50 of 0.7 nM. In contrast, the IC50 of vardenafil for PDE1 is 180 nM; for PDE6, 11 nM; for PDE2, PDE3 and PDE4, more than 1000 nM[4]. Vardenafil significantly enhanced the sodium nitroprusside (SNP)-induced relaxation of human trabecular smooth muscle at 3 nM. It also significantly potentiated both ACh-induced and transmural electrical stimulation-induced relaxation of trabecular smooth muscle[4]. In vivo studies in rabbits showed that orally administered vardenafil dose-dependently potentiated erectile responses to intravenously administered SNP. The minimal effective dose that significantly potentiated erection was 0.1 mg/kg. The selectivity for PDE5, the potentiation of NO-induced relaxation and cGMP accumulation in human trabecular smooth muscle and the ability to enhance NO-induced erection in vivo indicated that vardenafil had the appropriate properties to be a potential compound for the treatment of erectile dysfunction[4]. Rats treated with vardenafil showed an improved object discrimination performance. Compared with sildenafil, vardenafil appeared to be even more potent in this respect since it already produced a high discrimination performance at a dose of 0.3 mg/kg[5]. |
| Concentration | Treated Time | Description | References | |
| Human T84 colonic epithelial cells | 30 µM | 1 h | To assess ST activity by measuring the induction of cGMP. | Cells. 2023 Feb 10;12(4):567. |
| Normal esophageal fibroblasts (NOFs) | 50 µM | 72 h | TGF-β1-treated NOFs expressed higher α-SMA, and Vardenafil pretreatment abrogated the TGF-β1-induced expression of α-SMA. | Cell Rep Med. 2022 Jun 21;3(6):100541. |
| Cancer-associated fibroblasts (CAFs) | 50 µM | 72 h | Vardenafil-treated CAFs showed a 50% reduction in α-SMA expression by Western blot and immunocytochemistry. | Cell Rep Med. 2022 Jun 21;3(6):100541. |
| Human T84 colonic epithelial cells | 30 µM | 1 h | To assess ST activity, T84 cells were pre-incubated with Vardenafil and Zardaverine, then treated with purified toxins or ETEC isolate supernatants for 2 h before cell lysis and cGMP measurement | Cells. 2023 Feb 10;12(4):567. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Patient-derived xenograft (PDX) model of esophageal adenocarcinoma | Oral | 16 mg/kg | Twice daily for 5 days | Vardenafil in combination with chemotherapy significantly reduced tumor volume and suppressed markers of CAF differentiation. | Cell Rep Med. 2022 Jun 21;3(6):100541. |
| Mice | F508del-CFTR mutant mice | Intraperitoneal injection | 0.14 mg/kg | Single dose | Vardenafil restores chloride transport across the nasal mucosa in F508del-CFTR mutant mice and attenuates lung inflammation by reducing cell infiltrates and pro-inflammatory cytokine expression. | Front Pharmacol. 2012 Sep 18;3:167 |
| Rats | Zucker diabetic fatty (ZDF) rats | Oral | 10 mg/kg | Once daily from 7 weeks to 32 weeks of age | Vardenafil effectively prevented the development of diabetes-associated heart failure with preserved ejection fraction (HFpEF) by maintaining diastolic function, restoring cGMP levels and PKG activation, lowering apoptosis, and alleviating nitro-oxidative stress, myocardial hypertrophy, and fibrotic remodeling. | Eur J Heart Fail. 2017 Mar;19(3):326-336 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT01063855 | Erectile Dysfunction ... 展开 >> Sexual Dysfunction 收起 << | Phase 3 | Completed | - | - |
| NCT01063855 | - | Completed | - | - | |
| NCT00767598 | Pharmacokinetics of Three PDE5... 展开 >>Is Healthy Subjects Genetic Polymorphic CYP3A5 收起 << | Phase 1 | Completed | - | - |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.73mL 0.35mL 0.17mL |
8.63mL 1.73mL 0.86mL |
17.27mL 3.45mL 1.73mL |
|
| CAS号 | 330808-88-3 |
| 分子式 | C23H39ClN6O7S |
| 分子量 | 579.11 |
| SMILES Code | O=C1N=C(C2=CC(S(=O)(N3CCN(CC)CC3)=O)=CC=C2OCC)NN4C1=C(C)N=C4CCC.[H]Cl.[H]O[H].[H]O[H].[H]O[H] |
| MDL No. | MFCD08458876 |
| 别名 | 盐酸瓦地那非三水合物 ;Vardenafil(hydrochloride hydrate); BAY38-9456; Vivanza; Staxyn; Levitra; Vardenafil HCl; Vardenafil hydrochloride trihydrate |
| 运输 | 蓝冰 |
| InChI Key | FBCDRHDULQYRTB-UHFFFAOYSA-N |
| Pubchem ID | 135413545 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, room temperature |
沪公网安备 31011702889066号
沪ICP备2024050318号-1